| |
| |
|
| Insider
Information: |
Barry Richard |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,175,488 |
|
|
Indirect Shares
|
3,881,612 |
|
|
| Direct
Value |
$364,267,841 |
|
|
|
Indirect Value
|
$58,613,421 |
|
|
| Total
Shares |
7,057,100 |
|
|
| Total
Value |
$422,881,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
2
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
2
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-2.0
|
| Percentage
Gain/Loss : |
 13.1%
|
 -81.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mabvax Therapeutics Holdings Inc |
MBVX |
10% Owner |
2012-12-17 |
243,800 |
2012-12-12 |
0 |
Premium* |
|
|
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-01 |
2,931,688 |
2024-03-01 |
250,000 |
Premium* |
|
|
Mimedx Group Inc |
MDXG |
Director |
|
0 |
2020-08-05 |
3,338,135 |
Premium* |
|
|
Cassava Sciences Inc |
SAVA |
Director |
|
0 |
2023-08-22 |
293,477 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SRPT |
Sarepta Therapeutics Inc |
|
– • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,846 |
2,931,688 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2023-11-03 |
4 |
B |
$78.81 |
$3,940,500 |
I/I |
50,000 |
140,000 |
2.1 |
% |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2023-08-22 |
4 |
B |
$16.65 |
$275,907 |
I/I |
16,571 |
293,477 |
2.1 |
% |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2023-08-21 |
4 |
B |
$16.80 |
$32,021 |
I/I |
1,906 |
276,906 |
2.1 |
% |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2023-03-07 |
4 |
B |
$25.76 |
$1,990,630 |
I/I |
77,276 |
275,000 |
2.1 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,523 |
2,929,842 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2023-03-06 |
4 |
B |
$26.13 |
$302,193 |
I/I |
11,565 |
197,724 |
2.1 |
% |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2022-08-23 |
4 |
B |
$23.79 |
$860,223 |
I/I |
36,159 |
186,159 |
2.1 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,953 |
2,928,319 |
0 |
- |
|
| SAVA |
Cassava Sciences Inc |
Director |
– • – |
2021-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
150,000 |
|
% |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,726 |
3,125,366 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-08-07 |
4 |
S |
$158.43 |
$4,754,972 |
D/D |
(30,000) |
3,129,140 |
0 |
% |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2020-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
38,135 |
3,338,135 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-05-15 |
4 |
S |
$141.12 |
$4,237,946 |
D/D |
(30,000) |
3,159,140 |
0 |
% |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,075 |
3,189,140 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-09-13 |
4 |
B |
$87.49 |
$289,504 |
D/D |
3,309 |
3,187,065 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-09-12 |
4 |
B |
$87.49 |
$147,950 |
D/D |
1,691 |
3,183,756 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-08-20 |
4 |
B |
$99.32 |
$496,593 |
D/D |
5,000 |
3,182,065 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-08-14 |
4 |
B |
$122.50 |
$453,250 |
D/D |
3,700 |
3,177,065 |
2.39 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-08-12 |
4 |
B |
$122.50 |
$159,250 |
D/D |
1,300 |
3,173,365 |
2.39 |
- |
|
| MDXG |
Mimedx Group Inc |
Director |
– • – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,300,000 |
|
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,633 |
3,172,065 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2018-06-27 |
4 |
AS |
$130.34 |
$9,775,500 |
D/D |
(75,000) |
3,170,432 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,418 |
3,245,432 |
0 |
- |
|
| SRPT |
Sarepta Therapeutics Inc |
Director |
– • – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
3,242,014 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
